We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current 0QWK market cap is 4.15B. The company's latest EPS is NOK -0.3928 and P/E is -91.65.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Revenue | 58.13M | 50.76M | 48.29M | 34.38M | 71.57M |
| Operating Income | -92.07M | -45.57M | -43.46M | -60.95M | -33.37M |
| Net Income | -101.79M | -60.01M | -46.33M | -65.73M | -45.24M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Assets | 131.48M | 161.66M | 121.85M | 118.9M | 152.39M |
| Total Liabilities | 34.29M | 27.4M | 25.85M | 24.55M | 33.53M |
| Total Equity | 97.19M | 134.25M | 96M | 94.35M | 118.86M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Operating | -80.37M | -47.68M | -32.38M | -56.63M | -61.68M |
| Investing | 40k | 489k | 626k | -13k | -597k |
| Financing | 61.3M | 83.27M | -2M | 54.94M | 58.11M |
| Market Cap | 4.15B |
| Price to Earnings Ratio | -91.65 |
| Price to Sales Ratio | 57.92 |
| Price to Cash Ratio | 66.21 |
| Price to Book Ratio | 34.88 |
| Dividend Yield | - |
| Shares Outstanding | 115.16M |
| Average Volume (1 week) | 270 |
| Average Volume (1 Month) | 4.28k |
| 52 Week Change | 0.00% |
| 52 Week High | 36.00 |
| 52 Week Low | 36.00 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Next Biometrics Group Asa |
| Address |
filipstad brygge 1 oslo 0250 |
| Website | https://www.nextbiometrics.com |
| Industry | semiconductor,related device (3674) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
